Koselugo (selumetinib) is a targeted therapy that works as a MEK inhibitor. It treats certain tumors caused by a genetic condition called neurofibromatosis type 1 (NF1). More specifically, it’s for adults and children 1 year and older with NF1 who have plexiform neurofibromas (PN), or small tumors around nerve tissue. Koselugo (selumetinib) comes as capsules and oral granules that are taken by mouth twice a day. But it can cause side effects like vomiting, diarrhea, and rash.
Koselugo (selumetinib) is a type of kinase inhibitor called a MEK inhibitor. It blocks a protein in the body called MEK, which is part of a signaling pathway that’s too active in people with NF1. This overactive signaling causes too much cell growth, leading to tumors like plexiform neurofibromas (PN).
When Koselugo (selumetinib) blocks the MEK protein, the signaling pathway gets disrupted. This stops the tumors from growing or spreading as well.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Children:
Adults:
Children:
Adults:
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Tips for Koselugo (selumetinib) capsules
Tips for Koselugo (selumetinib) oral granules
Koselugo (selumetinib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Koselugo (selumetinib) can affect how well the heart pumps blood. In studies, some people had lower heart function, which was found on heart ultrasounds (echocardiograms). This has happened during the first year of treatment and got better a few months later.
Before starting Koselugo (selumetinib), you'll need an echocardiogram to check how well your heart is working. During treatment, you'll also have regular heart scans. In some cases, you might need a different kind of heart scan called a cardiac MRI.
If any signs of heart problems show up on your scans, your NF1 specialist will probably have you stop Koselugo (selumetinib) until your heart improves. Then, you might be able to restart the medication at a lower dose. If the heart problem is serious, the specialist might stop treatment completely.
Tell your care team right away if you have any symptoms of heart problems. Look out for cough or wheezing that doesn’t go away, shortness of breath, swelling of your ankles or feet, tiredness, or a fast heart rate.
Koselugo (selumetinib) can cause eye problems like blurry vision and sensitivity to bright light. Some eye problems can be more serious. This includes higher eye pressure, cataracts, or damage to the retina.
Before you start Koselugo (selumetinib), an eye specialist (ophthalmologist) will do a detailed eye exam. You'll also need regular eye exams during treatment.
Tell your NF1 specialist and ophthalmologist right away if there are any new or worsening changes in vision. They’ll do more eye exams to check what’s going on. If needed, the specialist might pause Koselugo (selumetinib) and restart it later at a lower dose. If the eye problem is very serious, you might need to stop the medication.
Koselugo (selumetinib) can often cause nausea, vomiting, mouth sores, and diarrhea. In studies, diarrhea usually happened within the first 2 months of treatment and sometimes lasted for about 5 to 7 days.
If you have diarrhea, call your NF1 specialist right away. They can tell you how to help stop diarrhea, such as using medication like loperamide (Imodium A-D) after the first loose stool. Make sure to drink plenty of fluids to prevent dehydration.
If the side effects are severe, the specialist might have you take a break from Koselugo (selumetinib) and restart later at a lower dose. In more severe cases, the specialist might decide to stop treatment completely.
Get medical help right away if you have severe stomach pain, swelling, nausea, vomiting, constipation, diarrhea, or bloody stools. These can be signs of a serious stomach problem that needs medical attention.
Koselugo (selumetinib) can often cause rashes. These rashes can be acne-like, raised, or itchy. Tell your NF1 care team if you notice any new or worsening rash, peeling skin, or blisters.
Depending on the type of rash, the specialist might suggest using moisturizers or other topical medications to help. They might also lower the Koselugo (selumetinib) dose, pause treatment, or stop the medication altogether.
Koselugo (selumetinib) can cause higher creatine phosphokinase (CPK) levels. This lab result can sometimes be a sign of muscle injury.
In studies, these lab changes were usually mild. But it sometimes led prescribers to lower the dose of Koselugo (selumetinib) or stop the medication. Also, most people didn’t have symptoms from higher CPK levels, but some also had muscle pain.
Your NF1 specialist will check your CPK levels with blood tests before starting Koselugo (selumetinib) and during treatment. If levels are high, they’ll try to figure out why. Also tell the specialist if you have muscle pain while taking this medication. The specialist might lower the dose, pause treatment, or stop the medication completely.
Koselugo (selumetinib) capsules contain vitamin E as one of the inactive ingredients. But too much vitamin E can interfere with how well your blood can clot. This can raise the risk of bleeding.
Talk to a healthcare professional before taking or giving any extra vitamin E, such as supplements. Also, tell your prescriber if you take blood thinners before starting Koselugo (selumetinib). These medications can raise the risk of bleeding even more. Your prescriber might need to monitor your bleeding risk or adjust your medications.
Koselugo (selumetinib) oral granules don’t contain vitamin E, so they don’t have this risk.
Based on animal studies and the way it works, Koselugo (selumetinib) could harm an unborn baby if taken while pregnant. If you can become pregnant, or can get someone pregnant, you should use effective birth control during treatment. Continue to use birth control for 1 week after your last dose of Koselugo (selumetinib). If you or your partner gets pregnant during treatment, tell the prescriber right away.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 60 capsules of oral granules of 5mg | 1 bottle | $4,144.80 | $4,144.80 |
| 60 capsules of oral granules of 7.5mg | 5 bottles | $31,008.00 | $6,201.60 |
Your NF1 specialist will help determine your dose. It’s based on your body surface area (BSA), which takes into account your height and weight.
Capsules
Oral granules
The dose might be different if you have liver problems or if you take certain medications that interact with Koselugo (selumetinib).
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.Health conditions
Medications & treatment
Access & affordability
Resources
No, Koselugo doesn’t cure NF1. But it can help slow or stop the growth of tumors called plexiform neurofibromas (PNs) in people with NF1. In studies, some had tumors that stayed the same size or got smaller after taking Koselugo for several months. For some children, it kept working for at least 3 years. Talk to your NF1 specialist to learn what to expect from treatment.
Koselugo isn't a type of traditional chemotherapy. It’s a targeted therapy that works on a specific protein in the body called MEK. In people with NF1, MEK is too active and it leads to tumors called plexiform neurofibromas (PNs). By blocking MEK, Koselugo helps stop the PNs from growing or spreading. This is different from traditional chemotherapy, which affects all fast-growing cells in the body.
The most common side effects of Koselugo are stomach upset and rash. If these become too hard for you to handle, let your care team know. They can recommend ways to help, like medication for nausea or diarrhea and moisturizing creams for rash.
It can. In studies, some people taking Koselugo had reduced heart function. Heart scans called echocardiograms showed that their heart wasn’t pumping as well. This problem usually only shows up on the scans. So your care team will do these tests regularly during treatment. This helps them monitor your heart as you take the medication. But tell your care team right away if you feel your heart beating fast, have swelling in the feet or ankles, have trouble breathing, or feel tired often. These could be signs of heart problems.
Talk to your care team before taking any vitamins or supplements. Koselugo capsules contain vitamin E. Taking more vitamin E than the recommended daily amount can raise the risk of bleeding. Ask a healthcare professional or pharmacist to check if a supplement has vitamin E and if it’s safe for you.
Yes. If you can become pregnant, or get someone pregnant, talk to your NF1 care team. You should use effective birth control while taking Koselugo and for 1 week after stopping the medication. This is important because Koselugo can harm an unborn baby. Your care team can talk about birth control options. Let your care team know right away if you or your partner gets pregnant during treatment.
If you have a baby and want to breastfeed, tell your NF1 care team. It’s not known if Koselugo passes into breast milk. But if it does, it could cause side effects in the baby. Because of this risk, avoid breastfeeding while taking Koselugo and for 1 week after the last dose. Ask your NF1 care team about safe ways for feeding.